We'll Be Back Soon
Subscriptions are temporarily on pause.
Explore the Business and Culture of Psychedelics
Get access to the psychedelics coverage that shapes the industry.
DIGITAL
$
7
99
per 3 months
-
Unlimited access on any device. Billed quarterly, cancel anytime.
PRINT + DIGITAL
$
9
99
per 3 months
-
Unlimited access on any device, with a print issue delivered to your mailbox every quarter. Billed quarterly, cancel anytime.
ANNUAL
(PRINT + DIGITAL)
$
34
99
per 1 year
-
Unlimited access on any device, with a print issue delivered to your mailbox every quarter. Billed annually.
Already a Subscriber?
Explore digital content now.
Psychedelia is a quarterly publication examining the ever-changing realm of drug policy and efforts to bring psychedelic therapies into the mainstream. From psilocybin mushrooms to LSD to DMT, psychedelics have the potential to revolutionize mental healthcare in North America. Psychedelia will detail the journey towards acceptance of psychedelic-assisted therapies.
